Funding
At the Costerton Biofilm Center we raised $11 million in competitive undiluted funding for the development of the drug target and proof-of-concept
Development
-
First Stage Award from Incubator for Antibacterial Therapies in Europe.
Fundamental research
-
6.62 mill DKK.
High-potency solution against biofilms – expanding the global arsenal against antibiotic resistance
-
1.5 mill DKK.
A drug for biofilm dissolution and clearance
-
0.25 mill DKK.
Co-therapy of a novel P. aeruginosa biofilm disruptor with standard of care antibiotics
-
3.5 mill DKK.
Biofilm 2: A procedure to dismantle and eradicate bacterial biofilms
-
5.3 mill DKK.
DK openscreen
-
3.9 mill DKK.
Danish Council for Independent Research. Antimicrobials designed to dismantle antibiotic resistant biofilms
-
10 mill DKK.
Identification of antimicrobials that can dismantle biofilms
-
5.3 mill DKK.
Danish Council for Independent Research. Mechanisms involved in bacterial biofilm formation and antimicrobial tolerance
-
2.8 mill DKK.
Research collaboration. Development of biofilm controlling chemistry to prevent biofilm formation in paper manufacturing machines
-
1.25 mill DKK.
-
2.0 mill DKK.
Biofilm 1: Identification of compounds that inhibit c-di-GMP synthesis in Pseudomonas aeruginosa
-
3.7 mill DKK.
Biofilms: a common course of Chronic infections
-
29 mill DKK.
Center for Antimicrobial Research
-
2.5 mill DKK.
Computer-based development of anti-pathogenic drugs